Re: So.....?
|
5
|
Resverlogix Corp.
|
Oct 14, 2017 04:08PM
|
Re: RVX announces...THIS IS FROM RVX
|
4
|
Resverlogix Corp.
|
Oct 13, 2017 11:29AM
|
Analysts coverage
|
3
|
Resverlogix Corp.
|
Oct 07, 2017 11:36AM
|
Re: Drug Discovery Targeting BRD4
|
4
|
Resverlogix Corp.
|
Oct 04, 2017 05:09PM
|
Re: Resolution?
|
1
|
Resverlogix Corp.
|
Oct 03, 2017 09:04AM
|
Re: Investor Boomtown Posts
|
|
Resverlogix Corp.
|
Oct 01, 2017 01:33PM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
1
|
Resverlogix Corp.
|
Sep 25, 2017 10:48AM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 24, 2017 11:23AM
|
Re: A couple of things....
|
2
|
Resverlogix Corp.
|
Sep 23, 2017 05:01PM
|
Re: Demoralizing....
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 04:01PM
|
Re: Has Kenneth Lebioda done presentations before?
|
|
Resverlogix Corp.
|
Sep 22, 2017 03:52PM
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Sep 22, 2017 03:36PM
|
Re: Has Kenneth Lebioda done presentations before?
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 09:21AM
|
Re: Demoralizing....
|
|
Resverlogix Corp.
|
Sep 21, 2017 09:19PM
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 21, 2017 06:21AM
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 20, 2017 08:48PM
|
Re: FA expectations
|
6
|
Resverlogix Corp.
|
Sep 20, 2017 10:13AM
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Sep 18, 2017 01:28PM
|
F6 at IV
|
4
|
Resverlogix Corp.
|
Sep 18, 2017 01:11PM
|
Re: The MD@A for the period ending July 31, 2017
|
3
|
Resverlogix Corp.
|
Sep 15, 2017 01:21PM
|